GenVec to Release Third Quarter 2011 Financial Results and Conduct a Conference
Call on November 9, 2011
GAITHERSBURG, Md., Nov. 2, 2011 /PRNewswire via COMTEX/ -- GenVec, Inc. (GNVC)
will report financial results for the third quarter of 2011 on Wednesday,
November 9, 2011, before the U.S. financial markets open. The announcement will
be followed by a webcast and conference call at 10:00 a.m. EST to discuss the
company's third quarter financial results and business outlook.
To listen to the live conference call, please dial 877-558-0567 (U.S. or Canada)
or 706-643-4980 (international) and use the following Conference ID: 23292607. An
audio replay of the conference call will be available starting at 1:00 p.m. EST
on November 9, 2011 through November 16, 2011. To listen to the audio replay,
dial 855-859-2056 or 404-537-3406 and use Conference Replay ID: 23292607.
To access the webcast or the replay, go to genvec.com, click on
"Investors and Media," and click on "Events and Presentations."
About GenVec
GenVec is a biopharmaceutical company using differentiated, proprietary
technologies to create superior therapeutics and vaccines. A key component of our
strategy is to develop and commercialize our product candidates through
collaborations. GenVec is working with leading companies and organizations such
as Novartis, Merial, and the U.S. Government to support a portfolio of product
programs that address the prevention and treatment of a number of significant
human and animal health concerns. GenVec's development programs address
therapeutic areas such as hearing loss and balance disorders; as well as vaccines
against infectious diseases including respiratory syncytial virus (RSV), herpes
simplex virus type 2 (HSV-2), dengue fever, and malaria. In the area of animal
health we are developing vaccines against foot-and-mouth disease (FMD).
Additional information about GenVec is available at genvec.com and in
the Company's various filings with the Securities and Exchange Commission. |
